Showing 51 - 60 of 1,275
Persistent link: https://www.econbiz.de/10003094157
Persistent link: https://www.econbiz.de/10002709522
Persistent link: https://www.econbiz.de/10001785484
This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....
Persistent link: https://www.econbiz.de/10013222052
Patent protection spurs innovation by raising the rewards for research, but it usually results in less desirable allocations after the innovation has been discovered. In effect, patents reward inventors with inefficient monopoly power. However, previous analysis of intellectual property has...
Persistent link: https://www.econbiz.de/10012466085
This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....
Persistent link: https://www.econbiz.de/10012468823
This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....
Persistent link: https://www.econbiz.de/10005084850
Patent protection spurs innovation by raising the rewards for research, but it usually results in less desirable allocations after the innovation has been discovered. In effect, patents reward inventors with inefficient monopoly power. However, previous analysis of intellectual property has...
Persistent link: https://www.econbiz.de/10005774382
Persistent link: https://www.econbiz.de/10005186068
We analyze the effect of price regulation on delays in launch of new drugs. Because a low price in one market may 'spill-over' to other markets, through parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a relatively low price. We...
Persistent link: https://www.econbiz.de/10005689825